Navigation Links
Genomic Health Announces Year-End 2010 Financial Results, Provides 2011 Financial Outlook
Date:2/8/2011

s delivered in 2009.  In the fourth quarter of 2010, more than 15,180 Oncotype DX test results were delivered, an increase of 14 percent, compared with more than 13,340 test results delivered in the same period in 2009.

2011 Financial GuidanceThe company is providing the following financial guidance for the full year ending December 31, 2011:

  • Total revenue of $200 to $210 million
  • Full-year net income of $3 to $5 million
  • Oncotype DX test results delivered of 63,000 to 66,000

  • "In 2011, we expect top-line revenue growth to be primarily driven by the breast cancer franchise as we continue to secure reimbursement for our colon cancer test," said Dean Schorno, Chief Financial Officer of Genomic Health.  "This year we intend to continue an increased level of investment in our business while targeting full year profitability consistent with 2010 levels."

    Fourth Quarter 2010 Highlights:Oncotype DX Breast Cancer Commercial Progress

  • Initiated breast cancer decision impact studies of Oncotype DX with clinical researchers in the United Kingdom and France.
  • Established a contract for estrogen-receptor positive breast cancer patients with Aviva Health Insurance Ireland Limited, a private payor covering approximately 300,000 lives in Ireland.
  • Signed contracts for payment with several hospitals in Germany.
  • Cigna, a large U.S. insurer, extended its coverage to include international members and patients with micrometastases.
  • Breast Cancer Research Treatment published positive results from a Japanese economic evaluation demonstrating that the inclusion of Oncotype DX in Japan's social health insurance benefit package for node-negative and node-positive breast cancer patients would be cost effective.
  • Established first distribution agreement in the Gulf Cooperation Council (GCC) region, in Kuwait.
  • Launched a Japanese langua
    '/>"/>

  • SOURCE Genomic Health, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    3. Personalized Medicine - The Genomic Revolution in Cardiac Care
    4. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
    5. Genomic Health Announces Preliminary Results From a Study of Oncotype DX(TM) in Node-Positive Breast Cancer Patients
    6. Microarray Sequence Capture Speeds Large-Scale Resequencing of Targeted Genomic Regions
    7. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
    8. Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium
    9. Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers
    10. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
    11. Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)... , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: ... Phase I trial of Lixte,s lead compound, LB‑100, is being ... John S. Kovach , M.D., the founder and ... to be completed at a single site. Accrual of patients, ...
    (Date:1/23/2015)... Ala. , Jan. 23, 2015 Gem Pharmaceuticals ... patients have been enrolled into the Company,s Phase 2 ... and safety of Gem,s lead compound, GPX-150 (an investigational ... advanced or metastatic disease. Logo - ...
    (Date:1/22/2015)...  Uroplasty, Inc. (NASDAQ: UPI ), a medical device ... to treat voiding dysfunctions, today reported financial results for ... Global revenue for the Company,s Urgent ®  PC ... quarterly revenue record, as compared to $3.9 million in ...
    Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 2Uroplasty Reports Record Revenue in Fiscal Third Quarter 3Uroplasty Reports Record Revenue in Fiscal Third Quarter 4Uroplasty Reports Record Revenue in Fiscal Third Quarter 5Uroplasty Reports Record Revenue in Fiscal Third Quarter 6Uroplasty Reports Record Revenue in Fiscal Third Quarter 7Uroplasty Reports Record Revenue in Fiscal Third Quarter 8Uroplasty Reports Record Revenue in Fiscal Third Quarter 9Uroplasty Reports Record Revenue in Fiscal Third Quarter 10Uroplasty Reports Record Revenue in Fiscal Third Quarter 11Uroplasty Reports Record Revenue in Fiscal Third Quarter 12Uroplasty Reports Record Revenue in Fiscal Third Quarter 13Uroplasty Reports Record Revenue in Fiscal Third Quarter 14Uroplasty Reports Record Revenue in Fiscal Third Quarter 15Uroplasty Reports Record Revenue in Fiscal Third Quarter 16Uroplasty Reports Record Revenue in Fiscal Third Quarter 17Uroplasty Reports Record Revenue in Fiscal Third Quarter 18
    ... 2, 2011 Lixte Biotechnology Holdings ... company has received a $244,479.25 grant under the ... further development and commercialization of Lixte,s novel anti-cancer compound LB-100. ... Protection and Affordable Care Act of 2010 to encourage development ...
    ... 2011 Joslin Diabetes Center has launched a groundbreaking ... Joslin, with technology from Forward Health Group, Inc., is ... with the critical capability to extract usefulness out of ... to combine this information with practice improvement support and ...
    Cached Medicine Technology:Lixte Biotechnology Holdings, Inc. Awarded Grant Under Qualifying Therapeutic Discovery Project from the U. S. Government 2Joslin Diabetes Center Launches Initiative to Resolve the Critical Link Connecting Continuing Medical Education (CME) to Sustained Quality Improvement 2Joslin Diabetes Center Launches Initiative to Resolve the Critical Link Connecting Continuing Medical Education (CME) to Sustained Quality Improvement 3
    (Date:1/22/2015)... a famous wedding dress company offering many trendy designs. Today, ... Twitter, and Pinterest. The fans will have an opportunity to ... week. , Moreover, the company has extended its 2015 New ... for more information. , Angelweddingdress is a famous ...
    (Date:1/22/2015)... January 22, 2015 A new white ... experience and person-centeredness in the long-term care environment as ... across the continuum. The paper, “The Power of Person-Centeredness ... perspectives and practices of the patient, resident and family ...
    (Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved television host, ... 32nd Annual Miami Breast Cancer Conference planned and ... , shares that “a fast-growing, virulent” cancer in her ... not followed up her clean mammogram with an ultrasound. ...
    (Date:1/22/2015)... Colorado (PRWEB) January 22, 2015 Four years since ... Queen – which coincided with the marriage of Avasa & Matthew ... THE ROAD, which is scheduled for release through White Swan Records ... message that there is a sacred path available to all of ...
    (Date:1/22/2015)... a new blog post presenting a list of vehicles that cannot ... Some types of vehicles cannot be covered under an ordinary auto ... see if their vehicle qualifies for auto insurance coverage. , ... that cannot be covered by a plan. Clients have little options ...
    Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
    ... supports the theory that bringing about senescence in aged ... ,Inducing senescence in aged cells may be sufficient to ... published online this week in European Molecular Biology Organization ... or programmed cell death – apoptosis – was the ...
    ... be sufficient to guard against spontaneous cancer development, ... in EMBO reports//. It was previously unknown whether ... – was the more important safeguard mechanism for ... cells have abnormal chromosomes with dysfunctional telomeres – ...
    ... dead due to the infection of a hospital superbug at ... Clostridium Difficile, commonly known as C diff, within the last ... of the patients were infected with a virulent strain of ... had to be performed on five other patients who had ...
    ... much of the molecular machinery required for life, are ... all proteins are membrane proteins – embedded within the ... the other two-thirds using such tools as antibodies, they ... portions of proteins. ,To probe the secrets ...
    ... at the University of Alabama at Birmingham's Magnetic Source ... , using MEG (magneto-encephalography) scanners to learn more about ... types of brain scans detail the geography of the ... the magnetic signals that neurons throw off as they ...
    ... -- Researchers have identified the receptor pathway used by ... The related report by Hsieh et al, “G protein-coupled ... nongenomic effects of estrogen in attenuating liver injury after ... Journal of Pathology and is accompanied by a commentary. ...
    Cached Medicine News:Health News:Penn Scientists Engineer Small Molecules to Probe Proteins Deep Inside Cell Membrane 2Health News:MEG Scanners Are Mega Powerful 2Health News:Estrogen Protects Liver After Traumatic Injury 2
    ... AQuify provides a completely new level ... and lubrication of both the lens ... This blink-activated product contains sodium hyalunorate, ... tear behavior on the eye. With ...
    Lens Plus rewetting drops for soft contact lenses....
    Renu rewetting drops soothe your eyes and moisturize soft contact lenses to minimize dryness....
    For use to rewet and lubricate lenses during wear. Soothes and moisturizes eyes while wearing soft contact lenses....
    Medicine Products: